NTR NTR
Company Profile ↓Company Overview
NTR (NTR) is a publicly traded company listed on with a market capitalization of $32.25B. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.
Why Investors Should Care
Trades at an undemanding P/E of 14.4.
Generates positive free cash flow, funding growth and shareholder returns internally.
Recent Developments
- Dec 2025 Revenue of $26.89B (+3.5% YoY); net profit $2.27B.
- Trailing 12 Months Year-on-year growth — revenue +3.5%, earnings +236.4%.
- 5-Year Trend Long-term compounding — revenue CAGR -10.8%, profit CAGR -33.4%.
Growth & Price Performance
Compounded Sales Growth
| 5 Years: | -10.80% |
| 1 Year: | 3.52% |
Compounded Profit Growth
| 5 Years: | -33.36% |
| 1 Year: | 236.35% |
Stock Price Performance
| 1 Year: | +15.16% |
| 6 Months: | -3.40% |
| 3 Months: | -12.57% |
| 1 Month: | +2.45% |
Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.
- Price vs 50-DMAAbove
- Price vs 200-DMAAbove
- Death Cross2d ago
- RSI (14)48.83 · Neutral
Auto-generated from price history and fundamentals; not investment advice.
Price Chart
Technical Trend
Computed from daily close history using EMA cross, slope, and RSI signals.
Note: intraday data is not stored locally. “Hourly” uses the most recent 10 daily candles as a short-term proxy.
Fundamental Growth Charts
No fundamental data available for this stock.
Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.
PROS
- Generates positive free cash flow.
CONS
- Revenue declined at -10.8% CAGR over 5 years.
- Earnings shrank at -33.4% CAGR over 5 years.
- In a downtrend (50-DMA below 200-DMA).
* The pros and cons are auto-generated from financial metrics.
Valuation
Growth (CAGR)
Profitability & Returns
Balance Sheet & Liquidity
Ownership
Financial Snapshot
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios
Quarterly Results
Figures in USD.
| Metric | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Revenue | - | 5.10B | 10.44B | 6.01B | 5.34B | 6.05B |
| Cost of Revenue | - | 3.78B | 7.26B | 4.04B | 3.45B | 4.40B |
| Gross Profit | - | 1.32B | 3.17B | 1.96B | 1.89B | 1.65B |
| Operating Expenses | - | 1.03B | 1.25B | 1.09B | 1.12B | 1.14B |
| Operating Income | - | 291.00M | 1.93B | 877.00M | 771.00M | 507.00M |
| EBITDA | - | 797.00M | 2.40B | 1.42B | 1.53B | 966.00M |
| Interest Expense | - | 179.00M | 155.00M | 170.00M | 225.00M | 176.00M |
| Pretax Income | - | 47.00M | 1.63B | 637.00M | 738.00M | 184.00M |
| Tax Provision | - | 28.00M | 398.00M | 168.00M | 158.00M | 45.00M |
| Net Income | - | 11.00M | 1.22B | 464.00M | 571.00M | 131.00M |
| Diluted EPS | - | 0.02 | 2.50 | 0.96 | 1.18 | 0.27 |
Profit & Loss (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | - | 37.88B | 29.06B | 25.97B | 26.89B |
| Cost of Revenue | - | 22.46B | 20.58B | 18.44B | 18.54B |
| Gross Profit | - | 15.42B | 8.47B | 7.53B | 8.35B |
| Operating Expenses | - | 5.24B | 4.61B | 4.57B | 4.48B |
| Operating Income | - | 10.18B | 3.86B | 2.96B | 3.87B |
| EBITDA | - | 12.78B | 4.88B | 4.21B | 6.15B |
| Interest Expense | - | 521.00M | 764.00M | 737.00M | 729.00M |
| Pretax Income | - | 10.25B | 1.95B | 1.14B | 3.05B |
| Tax Provision | - | 2.56B | 670.00M | 436.00M | 752.00M |
| Net Income | - | 7.66B | 1.26B | 674.00M | 2.27B |
| Diluted EPS | - | 14.18 | 2.53 | 1.36 | 4.66 |
Balance Sheet (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Total Assets | - | 54.59B | 52.75B | 51.84B | 52.30B |
| Current Assets | - | 16.34B | 14.17B | 13.79B | 14.75B |
| Cash & Equivalents | - | 901.00M | 941.00M | 853.00M | 701.00M |
| Inventory | - | 7.63B | 6.34B | 6.15B | 6.98B |
| Receivables | - | 5.60B | 4.67B | 4.63B | 5.08B |
| Total Liabilities | - | 28.72B | 27.55B | 27.40B | 26.94B |
| Current Liabilities | - | 14.28B | 12.12B | 12.04B | 11.04B |
| Long Term Debt | - | 8.04B | 8.91B | 8.88B | 9.35B |
| Total Debt | - | 11.93B | 12.57B | 12.81B | 12.02B |
| Total Equity | - | 25.82B | 25.16B | 24.41B | 25.32B |
| Shares Outstanding | - | 507.25M | 494.55M | 491.03M | 481.96M |
Cash Flows (Annual)
Figures in USD.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | 8.11B | 5.07B | 3.54B | 4.01B |
| Investing Cash Flow | - | -2.90B | -2.96B | -2.13B | -1.37B |
| Financing Cash Flow | - | -4.73B | -2.06B | -1.45B | -2.82B |
| Capital Expenditure | - | -2.48B | -2.60B | -2.15B | -2.00B |
| Free Cash Flow | - | 5.63B | 2.47B | 1.38B | 2.00B |
| Net Change in Cash | - | 478.00M | 47.00M | -51.00M | -182.00M |
Ratios (Annual)
Figures in %.
| Metric | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Gross Margin % | - | 40.7% | 29.2% | 29.0% | 31.0% |
| Operating Margin % | - | 26.9% | 13.3% | 11.4% | 14.4% |
| Net Margin % | - | 20.2% | 4.3% | 2.6% | 8.4% |
| ROE % | - | 29.7% | 5.0% | 2.8% | 9.0% |
| ROCE % | - | 25.3% | 9.5% | 7.4% | 9.4% |
Shareholding Pattern
Analyst View
Analyst aggregate. Targets and ratings update periodically; not investment advice.
Latest News
Recent headlines for NTR
Nutrien Ltd. (NTR) Releases Q2 2026 Earnings: Revenue Growth and Higher EPS - Quiver Quantitative
<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxOSHhnRTBVellhNW5hUXdRY1JWczA3UnVOVW9MTHZPYUg5cldXamxiUzVRS2VnY1UzZUtMME1rSXFsZWpWZHJDV2JwXzltMzRfZEg1cGZ5alNSVTEyMllESUhBLWZKTUtOdjZKaWJSaW9CREI0a3pITTdqTVdNLUNiVktPMV90RmJ3ZlRHUX…
Earnings Flash (NTR) Nutrien Ltd. Posts Q2 Adjusted EPS $2.61 per Share, vs. FactSet Est of $2.71 - marketscreener.com
<a href="https://news.google.com/rss/articles/CBMi2wFBVV95cUxNWkpPQjFaVC1GX3hjQTlodVFQSkxTU0wySmxSQktqaS1NMlczVVp6WTNGMWZTNnpGNHdLOHVJVFVvQkF6a2tta0EzRTJzR2pUM2daaUFvM3FfZW9adHZxSjBrWGZMRUxrRUw3Z3lheFppNGxKYWJkWjk0a0lrSzYtOE1uLUJnZEo2U2NYZE…
Nutrien (TSX:NTR) Stock Could Be Below Fair Value Despite Fertilizer Push - Yahoo Finance
<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxPMmhVN3M4VmpQWWQ2UnhoaExCc0w3cWl3eE9ybXhWTE0wVjlmX29oOFpjMDhBRkVHTUQ2QzJjV1RJTm53ZzhxWjVGVE9ZR1h3R1VjbEZBTlRmeXExZTVxbWxQSVIteTB6amZQSkt4bEZFYzZYXzlvZExmMlE0cjRFVlBsdUQ3WHZFbUZac2…
Nutrien Ltd (NTR) Shares Fall 4.5% -- GF Value Says Still Overva - GuruFocus
<a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxQcjJRcF8zMkdQWW9PSWxEdXFuNkNUMGxRVzlkWkNLbkZpQUhFWjdMQW5WbVdtelliMXR2UzY4bGxSOUNlTTBCcm8zbXNiY29QSWFYZV9zd1pKUXhXLUdRWTBKX3NGWng1NGJYaXp3QXM5U2NMcHh3cmVXN2pSdjdBWGRiVVlnbVA4U0JjV1…
Nutrien Falls as Investors Weigh a Recent Analyst Downgrade and Near-Term Earnings Risk - Moomoo
<a href="https://news.google.com/rss/articles/CBMiqAFBVV95cUxQOWZ5ZThSdHBpdy1kSUhqeFc5S1E1QTk5bGpRa3lUaENXREN4eGRTb2VxZWhCbFdyRjhFQW10SWNxMFpOOWEydEZtODl1a2haOXpsdU53VkVacVBueFppTDRLUDRfTWpBVXJjQUtPSzNFUkl0RElUTHQ4QUhwbWtBUlVuVG5DQjVYV0pnS0…
Nutrien Increases Quarterly Dividend and Announces Intent to Launch a New Share Repurchase Program - Nutrien
<a href="https://news.google.com/rss/articles/CBMi4AFBVV95cUxOTVBSU0NxYV9GZ05TaVNoYUFmSnBPaW1TUVZDVDY4WFdGM1dXOThvUWhoc05WeEhTWjJNa1ZQdGZSMFlwMVJIbGdCUFVXY0lvOUJlVlY2TjVzSmRzSHFCU0NWbjRoV3pEUzA5Y0xLd3dLcVZLeHpKbW5nbVl6ZnFIdEtVQkFHLVR5dzFfVj…
NTR — Frequently Asked Questions
What is the current share price of NTR?
As of 2026-08-05 17:25 PDT, NTR trades at $66.92 on NASDAQ/NYSE. Its 52-week range is $52.78 to $82.59.
What is the market capitalisation of NTR?
NTR has a market capitalisation of $32.25B on NASDAQ/NYSE.
What is the P/E ratio of NTR?
NTR trades at a trailing price-to-earnings (P/E) ratio of 14.36. Its price-to-book (P/B) ratio is 1.27.
What is the return on equity (ROE) of NTR?
NTR has a return on equity (ROE) of 8.95%. Its return on capital employed (ROCE) is 9.38%.
Is NTR a good stock to buy?
This page provides a data-driven analysis of NTR, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.